Sema4 Corp. (SMFR)
0.31
0.07 (26.53%)
At close: Jan 10, 2023, 5:00 AM
26.53% (1D)
| Bid | n/a |
| Market Cap | 246.37M |
| Revenue (ttm) | 305.45M |
| Net Income (ttm) | -52.29M |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | 0 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 4,706,661 |
| Avg. Volume (20D) | 2,009,536 |
| Open | 0.26 |
| Previous Close | 0.24 |
| Day's Range | 0.26 - 0.33 |
| 52-Week Range | 0.22 - 4.09 |
| Beta | 0.00 |
About SMFR
Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial su...
Sector Healthcare
IPO Date Nov 4, 2020
Employees 1,200
Stock Exchange NASDAQ
Ticker Symbol SMFR
Website https://www.sema4.com